Yehudit Shabat

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Gadi Lalazar, Meir Mizrahi, Ilit Turgeman et al. · Journal of Clinical Immunology · 2015 · 75 citations

Autoimmune Disease, Insulin Management, Diabetes +9

Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH

Ami Ben Yaʼacov, Meir Mizrahi, Yehudit Shabat et al. · Journal of Inflammation Research · 2012 · 71 citations · Full text

Extracts from <i>Lentinula edodes</i> (Shiitake) Edible Mushrooms Enriched with Vitamin D Exert an Anti-Inflammatory Hepatoprotective Effect

Ariel Drori, Yehudit Shabat, Ami Ben Yaʼacov et al. · Journal of Medicinal Food · 2016 · 43 citations

CpG-Induced Myeloid CD11b+Gr-1+ Cells Efficiently Suppress T Cell–Mediated Immunoreactivity and Graft-Versus-Host Disease in a Murine Model of Allogeneic Cell Therapy

Shoshana Morecki, Yael Gelfand, Elena Yacovlev et al. · Biology of Blood and Marrow Transplantation · 2008 · 39 citations

Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage

Yehudit Shabat, Yoav Lichtenstein, Yaron Ilan · Inflammation · 2020 · 30 citations

Inflammation, Host Response, Liver Physiology +8